Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_assertion type Assertion NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_head.
- NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_provenance.
- NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_assertion evidence source_evidence_literature NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_provenance.
- NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_assertion SIO_000772 10029588 NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_provenance.
- NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_assertion wasDerivedFrom befree-20150227 NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_provenance.
- NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_assertion wasGeneratedBy ECO_0000203 NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_provenance.